Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study.
|
30964707 |
2019 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.
|
29441810 |
2018 |
Coronary Arteriosclerosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR-γ, LP(a), IL-1 and TNF-α in Type 2 Diabetic Patients with Coronary Heart Disease.
|
28916975 |
2017 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Rosmarinic Acid Protects against Inflammation and Cardiomyocyte Apoptosis during Myocardial Ischemia/Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma.
|
28744220 |
2017 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han Population.
|
28415751 |
2017 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
PGC-1α (Peroxisome Proliferator-Activated Receptor γ Coactivator 1-α) Overexpression in Coronary Artery Disease Recruits NO and Hydrogen Peroxide During Flow-Mediated Dilation and Protects Against Increased Intraluminal Pressure.
|
28533333 |
2017 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Atrial natriuretic peptide induces peroxisome proliferator activated receptor γ during cardiac ischemia-reperfusion in swine heart.
|
27510704 |
2017 |
Coronary Arteriosclerosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma.
|
27150726 |
2016 |
Coronary Arteriosclerosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
The coronary artery disease-associated gene C6ORF105 is expressed in human macrophages under the transcriptional control of PPARγ.
|
25595457 |
2015 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Since accumulating data support the role of PPAR-γ polymorphisms in CAD, further studies are required to investigate the association of this polymorphism with coronary artery disease.
|
25896411 |
2015 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis.
|
23266668 |
2013 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
|
23583468 |
2013 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.
|
23065280 |
2013 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
|
22987045 |
2012 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.
|
23300871 |
2012 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association between C1431T polymorphism in peroxisome proliferator-activated receptor-γ gene and coronary artery disease in Chinese Han population.
|
21643757 |
2012 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population.
|
22515931 |
2012 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
|
21861709 |
2012 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
PPAR-γ and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy.
|
21536015 |
2011 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.
|
21548985 |
2011 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
|
20334678 |
2010 |
Coronary Arteriosclerosis
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Thus ADRB2 and GPR74 genes are associated with adipocyte lipolysis, GPR74 also with BMI; PPARG and SREBP1, which promote adipogenesis and lipid storage, are associated with T2D and possible adiposity; ADIPOQ and ARL15 are associated with circulating levels of adiponectin, ARL15 also with coronary heart disease.
|
21036322 |
2010 |
Coronary Arteriosclerosis
|
0.200 |
Biomarker
|
disease |
BEFREE |
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
|
20430250 |
2010 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.
|
17322631 |
2007 |
Coronary Arteriosclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
|
17892998 |
2007 |